Lung Cancers Completed Phase 2 / 3 Trials for Rebimastat (DB06573)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006229Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung CancerTreatment